The Prevelance of Pulmonary Manifestation in Patients With Inflammatory Bowel Disease

The Prevelance and Complications of Pulmonary Manifestations in Patients With Inflammatory Bowel Disease Clinical Trial

Official title:

The Prevelance of Pulmonary Manifestations in Patients With Inflammatory Bowel Disease

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04613466
• Other study ID #: Gateroentrolgy unit
• Status: Not yet recruiting
• Start date: December 1, 2020
• Est. completion date: June 1, 2022

Study information

• Verified date: November 2020
• Source: Assiut University
• Contact: Hussein Elamin
• Phone: 01004084187
• Email: sehshammam[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Bronchopulmonary manifestations signs and symptoms are variable extraintestinal manifestations of IBD.

Description:

Several cases like bronchiactsis, bronchitis, tracheobronchitis and broncholitis. None of this complications are specific for either crohns or ulcerative , however the majority of cases are related to ulcerative colitis.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: June 1, 2022
• Est. primary completion date: December 1, 2021
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:All patients diagnosed ulcerative colitis and crohns disaese on conventional treatment and biological treatment - Exclusion Criteria:no exclusion criteria -

Related Conditions & MeSH terms

• Inflammatory Bowel Diseases
• Intestinal Diseases
• The Prevelance and Complications of Pulmonary Manifestations in Patients With Inflammatory Bowel Disease

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The presence of pulmonary manifestations in IBD patients		1 year